ANI Pharmaceuticals, Inc

(NASDAQ:ANIP)

Latest On ANI Pharmaceuticals, Inc (ANIP):

Date/Time Type Description Signal Details
2023-05-31 02:07 ESTNewsANI Pharmaceuticals: Strong Revenue Growth And ANDA ApprovalsN/A
2023-05-15 20:53 ESTNewsANI Pharma gains as FDA clears generics for Celontin and FosamaxN/A
2023-05-12 20:30 ESTNewsANI Pharmaceuticals down 6%, prices $75M offeringN/A
2023-05-12 06:14 ESTNewsANI Pharmaceuticals announces proposed stock offering, shares fall 6% after hoursN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals soars ~10% after Q1 beat, raises outlook amid rare disease focusN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:43 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31MN/A
2023-05-05 23:59 ESTNewsANI Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-24 15:29 ESTNewsANI Pharmaceuticals stock rises after FDA approval of generic antibioticN/A
2023-04-04 10:27 ESTNewsANI Pharma's generic cholesterol-lowering drug gets FDA approvalN/A
2023-03-10 04:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 13:04 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06MN/A
2023-03-08 22:19 ESTNewsANI Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-03-01 22:47 ESTNewsANI Pharma draws Buy at Guggenheim on potential of autoimmune therapyN/A
2023-01-01 20:02 ESTNews2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To BenefitN/A
2022-12-20 07:38 ESTNewsANI Pharmaceuticals gets FDA approval for generic levocarnitine tabletsN/A
2022-11-16 07:53 ESTNewsANI Pharmaceuticals launches generic antibiotic trimethoprim with FDA approval in bagN/A
2022-11-09 20:16 ESTNewsANI Pharmaceuticals reports Q3 earnings beat; reaffirms FY22 guidanceN/A
2022-11-09 20:14 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 02:13 ESTNewsANI Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-09-14 00:52 ESTNewsANI Pharmaceuticals (ANIP) presents at H.C. Wainwright 24th Annual Global Investment Conference - SlideshowN/A
2022-08-30 01:03 ESTNewsANI Pharma launches generic Prochlorperazine maleate tabletsN/A
2022-08-16 21:11 ESTNewsANI Pharmaceuticals' generic dexamethasone tablets get FDA approvalN/A
2022-08-08 18:58 ESTNewsANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for CortrophinN/A
2022-08-08 18:57 ESTNewsANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecastN/A
2022-08-08 18:57 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:37 ESTNewsANI Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-22 15:19 ESTNewsANI Pharmaceuticals' generic drug for anxiety disorder gets FDA approvalN/A
2022-06-22 15:18 ESTNewsHot Stocks: WGO rises on earnings, ANIP gains on FDA approval, AVT pops on new partnership, while ORA fallsN/A
2022-06-02 21:40 ESTNewsANI Pharmaceuticals to cease operations at Oakville, Canada manufacturing plantN/A
2022-06-02 03:17 ESTNewsANI Pharma rises after hours on FDA approval for fludrocortisone acetate tabletsN/A
2022-05-10 23:50 ESTNewsANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55MN/A
2022-05-10 23:49 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 01:59 ESTNewsANI Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-15 16:49 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.54 misses by $0.20, revenue of $60.9M beats by $4.6MN/A
2022-03-15 16:48 ESTNewsANI Pharma reaches a seven-month low on soft guidance for 2022N/A
2022-03-15 16:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-14 23:38 ESTNewsANI Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-09 07:25 ESTNewsANI Pharmaceuticals: Back In The Buy ZoneN/A
2022-01-12 18:27 ESTNewsFTC final order settling antitrust charges clears way for ANI acquisition of NovitiumN/A
2021-12-21 16:27 ESTNewsANI Pharmaceuticals announces FDA approval of Mycobutin genericN/A
2021-11-11 21:20 ESTNewsANI Pharma acquisition of Novitium cleared by FTCN/A
2021-11-11 01:06 ESTNewsANI Pharma, Novitium to divest two generic products as part of mergerN/A
2021-11-04 03:50 ESTNewsANI Pharmaceuticals launches stock offeringN/A
2021-11-01 15:13 ESTNewsFDA grants expanded approval for ANI Pharmaceuticals' Cortrophin GelN/A
2021-11-01 15:13 ESTNewsANI Pharmaceuticals EPS beats by $0.31, beats on revenueN/A
2021-11-01 15:11 ESTNewsANI Pharma surges 44% following strong earnings, expanded approval; hits 52-week highN/A
2021-11-01 15:10 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-31 19:33 ESTNewsANI Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-02 06:16 ESTNewsANI Pharmaceuticals (ANIP) Investor Presentation - SlideshowN/A

About ANI Pharmaceuticals, Inc (ANIP):

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.

ANIP Quotes by TradingView

See Advanced Chart

General

  • Name ANI Pharmaceuticals, Inc
  • Symbol ANIP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 369
  • Last Split Factor1:6
  • Last Split Date2013-07-18
  • Fiscal Year EndDecember
  • IPO Date2000-05-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.anipharmaceuticals.com
View More

Valuation

  • Trailing PE 77.58
  • Forward PE 8.31
  • Price/Sales (Trailing 12 Mt.) 1.75
  • Price/Book (Most Recent Quarter) 1.84
  • Enterprise Value Revenue 2.59
  • Enterprise Value EBITDA 19.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.44
  • Next Year EPS Estimate $4.43
  • Next Quarter EPS Estimate $0.87
  • Profit Margin -11%
  • Operating Margin -2%
  • Return on Assets -1%
  • Return on Equity -11%
  • Revenue 208.48 million
  • Earnings Per Share $1.34
  • Revenue Per Share $17.43
  • Gross Profit 125.62 million
  • Quarterly Earnings Growth 19.4%
View More

Highlights

  • Market Capitalization 408.05 million
  • EBITDA 39.87 million
  • PE Ratio 55.14
  • PEG Ratio 1.06
  • Analyst Target Price $38.33
  • Book Value Per Share $16.31
View More

Share Statistics

  • Shares Outstanding 12.35 million
  • Shares Float 9.25 million
  • % Held by Insiders 474%
  • % Held by Institutions 79.46%
  • Shares Short 542783
  • Shares Short Prior Month 521318
  • Short Ratio 10.51
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.23
  • 52 Week High $52.22
  • 52 Week Low $23.55
  • 50 Day Moving Average 30.62
  • 200 Day Moving Average 29.54
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ANI Pharmaceuticals, Inc (ANIP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ANI Pharmaceuticals, Inc (ANIP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$57.25 million$0.80$0.94-15.19%
2020-09-302020-11-05$52.98 million$0.97$0.889.82%
2020-06-302020-08-06$N/A$0.69$0.75-7.59%
2020-03-312020-05-07$N/A$1.04$0.8916.85%
2019-12-312020-02-27$47.97 million$1.08$1.18-8.73%
2019-09-302019-11-06$51.34 million$1.23$1.43-13.99%
2019-06-302019-08-07$54.36 million$1.44$1.2912.06%
2019-03-312019-05-09$52.89 million$1.30$1.0524.2%
2018-12-312019-02-27$57.12 million$1.32$1.246.45%
2018-09-302018-11-06$50.7 million$1.29$1.1710.26%
2018-06-302018-08-07$47.27 million$1.13$1.34-15.67%
2018-03-312018-05-08$46.48 million$1.32$1.283.53%
2017-12-312018-02-27$47.29 million$1.08$1.053.35%
2017-09-302017-11-02$48.16 million$1.11$0.9912.12%
2017-06-302017-08-03$44.76 million$0.98$0.8613.95%
2017-03-312017-05-04$36.63 million$0.74$0.79-6.33%
2016-12-312017-03-02$38.21 million$0.90$1.10-18.18%
2016-09-302016-11-03$38.53 million$1.09$1.081.24%
2016-06-302016-08-04$31.34 million$1.11$0.7744.16%
2016-03-312016-05-05$20.56 million$0.76$0.708.57%
2015-12-312016-02-23$18.04 million$0.52$0.58-9.57%
2015-09-302015-11-03$19.97 million$0.80$0.5642.86%
2015-06-302015-08-04$19.52 million$0.55$0.541.85%
2015-03-312015-05-05$18.8 million$0.57$0.561.79%
2014-12-312015-02-19$21.04 million$0.42$0.59-28.81%
2014-09-302014-11-03$17.39 million$0.66$0.4643.48%
2014-06-302014-08-04$6.65 million-$0.21-$0.01-2000%
2014-03-312014-05-05$10.9 million$0.33$0.323.13%
2013-12-312014-02-18$15.95 million$0.41$0.2470.83%
2013-09-302013-11-07$7.84 million$0.13
2013-06-302013-08-09$6.15 million-$6.02
2013-03-312013-05-13$145040-$0.56
2012-12-312013-03-01$1.97 million-$1.10
2012-09-302012-11-08$110383-$1.62-$1.8010%
2012-06-302012-08-01$108780-$2.16-$2.4612.2%
2012-03-312012-05-08$114000-$3.24-$1.98-63.64%
2011-12-312012-03-13-$2.16-$4.0546.67%
2011-09-302011-11-09$182784-$4.32-$5.1015.29%
2011-06-302011-07-25$81003-$5.76-$6.4811.11%
2011-03-312011-05-10-$7.20-$5.18-39%
2010-12-312011-03-16-$6.48-$5.31-22.03%
2010-09-302010-11-12-$5.76-$5.04-14.29%
2010-06-302010-08-12-$6.12-$3.78-61.9%
2010-03-312010-05-14-$6.84-$3.78-80.95%
2009-12-312010-03-30-$31.32-$3.96-690.91%
2009-09-302009-11-09-$7.56-$5.76-31.25%
2009-06-302009-08-07-$6.12-$5.40-13.33%
2009-03-312009-05-11-$5.40-$5.766.25%
2008-12-312009-03-16-$1.80-$8.6479.17%
2008-09-302008-11-10-$8.64-$7.20-20%
2008-06-302008-08-11-$7.92-$5.76-37.5%
2008-03-312008-05-09-$4.68-$3.60-30%
2007-12-312008-03-17-$2.16-$2.8825%
2007-09-302007-11-13-$2.16-$3.6941.46%
2007-06-302007-08-14-$3.60-$3.24-11.11%
2007-03-312007-05-01-$2.88-$2.880%
2006-12-312007-03-08$15.84-$2.88650%
2006-09-302006-11-14-$1.08-$4.1473.91%
2006-06-302006-08-14-$3.96-$5.2224.14%
2006-03-312006-05-12-$6.12-$6.485.56%
2005-12-312006-03-31-$4.68-$4.41-6.12%
2005-09-302005-11-10-$3.60-$4.8625.93%
2005-06-302005-08-12-$4.68-$5.4013.33%
2005-03-312005-05-13-$5.04-$5.223.45%
2004-12-312005-02-15-$7.92-$6.30-25.71%
2004-09-302004-11-12-$5.76-$5.760%
2004-06-302004-08-16-$5.55
2004-03-312004-05-17-$6.12-$4.32-41.67%
2003-12-312004-03-09-$3.96
2003-09-302003-11-12-$4.31
2003-06-302003-08-16-$6.41
2003-03-312003-05-15-$4.96
2002-12-312002-12-31-$1.97
2002-09-302002-09-30-$3.91
2002-06-302002-06-30-$7.93
2002-03-312002-03-31-$5.85
2001-12-312001-12-31-$7.84
2001-09-302001-09-30$1.87

ANI Pharmaceuticals, Inc (ANIP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ANI Pharmaceuticals, Inc (ANIP) Chart:

ANI Pharmaceuticals, Inc (ANIP) News:

Below you will find a list of latest news for ANI Pharmaceuticals, Inc (ANIP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ANI Pharmaceuticals, Inc (ANIP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-17450CALL0 0106.33TRUE00
2026-04-17500CALL0 089.73TRUE00
2026-04-175536CALL0 159.68TRUE00
2026-04-17600CALL0 064.62TRUE00
2026-04-17650CALL0 058.63TRUE00
2026-04-177015.52CALL0 145.72TRUE00
2026-04-17755.31CALL0 238.33FALSE00
2026-04-17802.3CALL0 150280.71FALSE00
2026-04-17850.55CALL1 80154.06FALSE0.550
2026-04-17900.85CALL0 30102.84FALSE00
2026-04-17950.2CALL0 49167.19FALSE00
2026-04-171000.7CALL0 19182.25FALSE00
2026-04-171050CALL0 0196FALSE00
2026-04-171107.2CALL0 1208.67FALSE00
2026-04-171154CALL0 1205.76FALSE00
2026-04-171201.05CALL0 0231.39FALSE00
2026-04-171250CALL0 0241.66FALSE00
2026-04-171300CALL0 0251.32FALSE00
2026-04-171350CALL0 0260.45FALSE00
2026-04-171400.7CALL0 7199.15FALSE00
2026-04-17450.85PUT0 4278.06FALSE00
2026-04-17501.25PUT0 2236.31FALSE00
2026-04-17551.5PUT0 1198.05FALSE00
2026-04-17600PUT0 0162.17FALSE00
2026-04-17650PUT0 0127.55FALSE00
2026-04-17701.9PUT0 564.81FALSE00
2026-04-17756.91PUT0 200545.21TRUE00
2026-04-17808PUT0 534.31TRUE00
2026-04-17855.6PUT0 20TRUE00
2026-04-17907.15PUT0 00TRUE00
2026-04-179512.5PUT0 056.59TRUE00
2026-04-1710013.69PUT0 00TRUE00
2026-04-1710529PUT0 074.16TRUE00
2026-04-1711030.11PUT0 089.04TRUE00
2026-04-1711531.5PUT0 096.98TRUE00
2026-04-1712036.3PUT0 0104.49TRUE00
2026-04-171250PUT0 0111.62TRUE00
2026-04-171300PUT0 0118.42TRUE00
2026-04-171350PUT0 0124.92TRUE00
2026-04-171400PUT0 0131.15TRUE00
2026-05-15400CALL0 094.38TRUE00
2026-05-15450CALL0 093.77TRUE00
2026-05-15500CALL0 079.09TRUE00
2026-05-15550CALL0 064.98TRUE00
2026-05-15600CALL0 061.32TRUE00
2026-05-15650CALL0 055.45TRUE00
2026-05-15700CALL0 053.71TRUE00
2026-05-15750CALL0 047.93FALSE00
2026-05-15800CALL0 053.21FALSE00
2026-05-15850CALL0 084.38FALSE00
2026-05-15900CALL0 096.55FALSE00
2026-05-15950CALL0 0107.35FALSE00
2026-05-151000CALL0 0117.1FALSE00
2026-05-151050CALL0 0126FALSE00
2026-05-151100CALL0 0134.19FALSE00
2026-05-15400PUT0 0210.24FALSE00
2026-05-15450PUT0 0180.15FALSE00
2026-05-15500PUT0 0153.21FALSE00
2026-05-15550PUT0 0128.53FALSE00
2026-05-15600PUT0 0105.39FALSE00
2026-05-15650PUT0 083.08FALSE00
2026-05-15700PUT0 051.65FALSE00
2026-05-15750PUT0 049.39TRUE00
2026-05-15800PUT0 051.49TRUE00
2026-05-15850PUT0 048.92TRUE00
2026-05-15900PUT0 040.34TRUE00
2026-05-15950PUT0 00TRUE00
2026-05-151000PUT0 00TRUE00
2026-05-151050PUT0 00TRUE00
2026-05-151100PUT0 062.99TRUE00
2026-07-174538.1CALL0 263.7TRUE00
2026-07-17500CALL0 055.88TRUE00
2026-07-17550CALL0 053.4TRUE00
2026-07-17600CALL0 049.64TRUE00
2026-07-176523.3CALL0 148.16TRUE00
2026-07-17700CALL0 046.88TRUE00
2026-07-17757.31CALL0 1146.5FALSE00
2026-07-17806CALL0 2045.81FALSE00
2026-07-17855.58CALL0 4346.67FALSE00
2026-07-17906.35CALL0 646.5FALSE00
2026-07-17956.9CALL0 152.85FALSE00
2026-07-171005CALL0 168.13FALSE00
2026-07-171050CALL0 077.65FALSE00
2026-07-171100CALL0 085.26FALSE00
2026-07-171152.4CALL0 278FALSE00
2026-07-171202.1CALL0 478.27FALSE00
2026-07-17450PUT0 0119.44FALSE00
2026-07-17501.7PUT0 0101.73FALSE00
2026-07-17550PUT0 085.51FALSE00
2026-07-17602.14PUT0 451.74FALSE00
2026-07-17653PUT0 1046.66FALSE00
2026-07-17704.7PUT0 200342.68FALSE00
2026-07-17758.7PUT0 1744.54TRUE00
2026-07-178010.25PUT0 2944.53TRUE00
2026-07-178514.4PUT0 444.4TRUE00
2026-07-17900PUT0 044.77TRUE00
2026-07-17950PUT0 042.5TRUE00
2026-07-1710025.9PUT0 8038.05TRUE00
2026-07-1710522.22PUT0 10TRUE00
2026-07-171100PUT0 044.59TRUE00
2026-07-171150PUT0 00TRUE00
2026-07-171200PUT0 054.72TRUE00
2026-10-16400CALL0 061.17TRUE00
2026-10-16450CALL0 056.7TRUE00
2026-10-16500CALL0 053.75TRUE00
2026-10-165524.6CALL0 149.77TRUE00
2026-10-166019.6CALL0 349.47TRUE00
2026-10-166517CALL0 248.95TRUE00
2026-10-167011.9CALL0 247.78TRUE00
2026-10-16750CALL0 047.75FALSE00
2026-10-16808.5CALL0 247.91FALSE00
2026-10-16857.56CALL0 147.74FALSE00
2026-10-16905.66CALL0 547.92FALSE00
2026-10-16950CALL0 048.07FALSE00
2026-10-161000CALL0 047.24FALSE00
2026-10-161050CALL0 053.76FALSE00
2026-10-161102.85CALL0 156.02FALSE00
2026-10-161150CALL0 067.79FALSE00
2026-10-161202.1CALL0 471.28FALSE00
2026-10-16400PUT0 0104.28FALSE00
2026-10-16450PUT0 089.6FALSE00
2026-10-16500PUT0 058.15FALSE00
2026-10-16550PUT0 048.09FALSE00
2026-10-16603.62PUT0 555.33FALSE00
2026-10-16650PUT0 046.23FALSE00
2026-10-16700PUT0 045.63FALSE00
2026-10-16750PUT0 045.49TRUE00
2026-10-168012.54PUT0 145.15TRUE00
2026-10-16850PUT0 045.76TRUE00
2026-10-169019.92PUT0 545.36TRUE00
2026-10-16950PUT0 044.18TRUE00
2026-10-1610027PUT0 3546.21TRUE00
2026-10-1610535PUT0 045.84TRUE00
2026-10-161100PUT0 045.7TRUE00
2026-10-161150PUT0 044.16TRUE00
2026-10-161200PUT0 00TRUE00

Latest ANIP Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST11182$24
Jun 13, 2022 7:58 PM EST140$24
Jun 13, 2022 7:59 PM EST100$24
Jun 13, 2022 7:59 PM EST3$23.98
Jun 13, 2022 7:59 PM EST10$24.005

ANI Pharmaceuticals, Inc (ANIP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2018-09-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018028121/0000000000-18-028121-index.htm
2018-10-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018032671/0000000000-18-032671-index.htm
2018-11-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018035326/0000000000-18-035326-index.htm
2020-07-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000020006407/0000000000-20-006407-index.htm
2019-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000021545719001016/0000215457-19-001016-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000083423720001478/0000834237-20-001478-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000102302420000008/0001023024-20-000008-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919057517/0001104659-19-057517-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465919060283/0001104659-19-060283-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919060284/0001104659-19-060284-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919067257/0001104659-19-067257-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919068992/0001104659-19-068992-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919069229/0001104659-19-069229-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920002449/0001104659-20-002449-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920005962/0001104659-20-005962-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920023089/0001104659-20-023089-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000110465920025744/0001104659-20-025744-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920025748/0001104659-20-025748-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041406/0001104659-20-041406-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041409/0001104659-20-041409-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041411/0001104659-20-041411-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044727/0001104659-20-044727-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/0001104659-20-044728-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044729/0001104659-20-044729-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044731/0001104659-20-044731-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046388/0001104659-20-046388-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049964/0001104659-20-049964-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049978/0001104659-20-049978-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920052874/0001104659-20-052874-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920053944/0001104659-20-053944-index.htm
2020-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920054478/0001104659-20-054478-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465920057791/0001104659-20-057791-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920057797/0001104659-20-057797-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920061654/0001104659-20-061654-index.htm
2020-05-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920064517/0001104659-20-064517-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920068029/0001104659-20-068029-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2020-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1023024/000110465920082375/0001104659-20-082375-index.htm
2020-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000110465920084013/0001104659-20-084013-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920089648/0001104659-20-089648-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091099/0001104659-20-091099-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091450/0001104659-20-091450-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920121560/0001104659-20-121560-index.htm
2018-05-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030783/0001144204-18-030783-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030785/0001144204-18-030785-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030787/0001144204-18-030787-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030788/0001144204-18-030788-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418041246/0001144204-18-041246-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042242/0001144204-18-042242-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418042444/0001144204-18-042444-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042460/0001144204-18-042460-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2018-09-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049849/0001144204-18-049849-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418055994/0001144204-18-055994-index.htm
2018-10-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418056446/0001144204-18-056446-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418057434/0001144204-18-057434-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418057627/0001144204-18-057627-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418066411/0001144204-18-066411-index.htm
2019-01-025Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419000179/0001144204-19-000179-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419004471/0001144204-19-004471-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419008991/0001144204-19-008991-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419010386/0001144204-19-010386-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000114420419010541/0001144204-19-010541-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419014333/0001144204-19-014333-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017759/0001144204-19-017759-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017765/0001144204-19-017765-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017770/0001144204-19-017770-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017773/0001144204-19-017773-index.htm
2019-04-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018181/0001144204-19-018181-index.htm
2019-04-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018185/0001144204-19-018185-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018898/0001144204-19-018898-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018899/0001144204-19-018899-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018900/0001144204-19-018900-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/0001144204-19-018901-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020281/0001144204-19-020281-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020282/0001144204-19-020282-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020283/0001144204-19-020283-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419023116/0001144204-19-023116-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419024656/0001144204-19-024656-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419024658/0001144204-19-024658-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026945/0001144204-19-026945-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419030641/0001144204-19-030641-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419036760/0001144204-19-036760-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419038053/0001144204-19-038053-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419038054/0001144204-19-038054-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/0001144204-19-041520-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002066/0001415889-20-002066-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002067/0001415889-20-002067-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002283/0001415889-20-002283-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000155837020009520/0001558370-20-009520-index.htm
2020-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1023024/999999999520001852/9999999995-20-001852-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000563/9999999997-19-000563-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000565/9999999997-19-000565-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719001398/9999999997-19-001398-index.htm
2019-07-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719005909/9999999997-19-005909-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001310/9999999997-20-001310-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001312/9999999997-20-001312-index.htm
2020-04-14CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001568/9999999997-20-001568-index.htm
2020-05-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720002915/9999999997-20-002915-index.htm

ANI Pharmaceuticals, Inc (ANIP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ANI Pharmaceuticals, Inc (ANIP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 474%
Institutional Ownership: 7946%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-04THOMAS HAUGHEYDirectorBuy3,000.0045.05135,150.0011,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2018-06-06Thomas A. PennDirectorBuy1,200.0012,310.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2020-04-10DAVID NASHDirectorBuy7,119.0012,355.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-10Patrick D WalshDirectorBuy9,255.0013,046.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2019-03-28Thomas A. PennDirectorBuy1,991.0014,301.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2018-06-06Robert E. JR BrownDirectorBuy1,200.0017,768.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-06DAVID NASHDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-06Patrick D WalshDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-06-06THOMAS HAUGHEYDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2020-04-10THOMAS HAUGHEYDirectorBuy7,119.0018,410.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-05-11Patrick D WalshInterim President and CEOBuy7,050.0020,096.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2019-05-15ARTHUR PRZYBYLPresident and CEOSell14,633.0069.251,013,335.25202,589.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-03-28Robert E. JR BrownDirectorBuy2,584.0020,352.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-03-18ARTHUR PRZYBYLPresident and CEOSell24,802.0063.531,575,671.06205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-03-19ARTHUR PRZYBYLPresident and CEOSell2,823.0063.51179,288.73205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,042.006.366,627.1221,394.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-14ARTHUR PRZYBYLPresident and CEOSell5,772.0070.45406,637.40217,222.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-20VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell5,512.0068.18375,808.162,219,259.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-19VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell2,067.0068.30141,176.102,224,771.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-16VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,349.0068.091,794,103.412,226,838.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-13ARTHUR PRZYBYLPresident and CEOSell9,595.0071.10682,204.50222,994.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-15VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell9,315.0069.34645,902.102,253,187.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,167.0033.0038,511.0022,561.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-08-14VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,360.0069.891,842,300.402,262,502.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-13VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell20,821.0071.771,494,323.172,288,862.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.4091,200.0023,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-08-12VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell21,016.0071.451,501,593.202,309,683.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-09VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell19,860.0071.701,423,962.002,330,699.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-03-28ARTHUR PRZYBYLPresident and CEOBuy37,280.00242,356.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-03-28STEPHEN P. CAREYVice President and CFOBuy12,451.0026,569.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy4,000.0030.98123,920.0027,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-08Nikhil LalwaniPRESIDENT & CEOBuy28,508.0028,508.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-04-10Robert E. JR BrownDirectorBuy7,119.0029,680.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.8992,670.0030,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-03-28DAVID NASHDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-03-28Patrick D WalshDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-03-28THOMAS HAUGHEYDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2018-09-11Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy28,688.006.60189,340.8047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell5,642.0064.44363,578.3847,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell1,503.0064.5096,943.5047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell4,651.0064.43299,645.7947,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy1,503.0033.0049,599.0049,345.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-24DAVID NASHDirectorBuy1,445.0068.7699,358.205,236.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy4,651.0033.00153,483.0052,493.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy5,642.0028.76162,263.9253,484.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell2,409.0071.13171,352.1755,927.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-03-28Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy12,451.0060,293.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-05-17James G. MarkenSVP Ops & Prod DevSell8,907.0070.67629,457.6961,230.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-15THOMAS HAUGHEYDirectorBuy2,500.0069.30173,240.006,291.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2020-04-10STEPHEN P. CAREYVice President and CFOBuy39,767.0063,145.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2019-05-14James G. MarkenSVP Ops & Prod DevSell4,917.0070.31345,714.2770,137.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2020-08-05Antonio R PeraDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-05Jeanne ThomaDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2019-03-28James G. MarkenSVP Ops & Prod DevBuy6,848.0075,928.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2020-03-03THOMAS HAUGHEYDirectorBuy2,000.0045.1890,360.008,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-04-10James G. MarkenSVP Ops & Prod DevBuy24,548.0085,297.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-10Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy39,767.0093,043.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm